TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE C

NCT07454642: AVA6103 in Subjects With Locally Advanced or Metastatic Selected Solid Tumors

Sponsor: Avacta Life Sciences Ltd · Phase: PHASE1 · Area: ONCOLOGY · Target Enrollment: 174 pts

Competing Trials Overlap

6 Active Trials

Excess Burn Exposure

$10,053,120

Rescue Site Savings

+$6,628,776

Unlock Full NCT07454642 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT07454642 Rescue Dossier →